News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,218 Results
Type
Article (42072)
Company Profile (272)
Press Release (686864)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (206569)
Career Advice (2044)
Deals (35884)
Drug Delivery (110)
Drug Development (82073)
Employer Resources (174)
FDA (16598)
Job Trends (15086)
News (349692)
Policy (33093)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2617)
Accelerated approval (33)
Adcomms (25)
Allergies (147)
Alliances (50244)
ALS (169)
Alzheimer's disease (1671)
Antibody-drug conjugate (ADC) (310)
Approvals (16865)
Artificial intelligence (524)
Autoimmune disease (156)
Automation (39)
Bankruptcy (362)
Best Places to Work (11703)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (177)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (640)
Cancer (4820)
Cardiovascular disease (398)
Career advice (1728)
Career pathing (36)
CAR-T (283)
CDC (47)
Celiac Disease (2)
Cell therapy (753)
Cervical cancer (36)
Clinical research (70092)
Collaboration (1718)
Company closure (4)
Compensation (1162)
Complete response letters (58)
COVID-19 (2773)
CRISPR (90)
C-suite (851)
Cystic fibrosis (147)
Data (6256)
Decentralized trials (2)
Denatured (25)
Depression (132)
Diabetes (500)
Diagnostics (6758)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (257)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90701)
Editorial (57)
Employer branding (21)
Employer resources (153)
Events (118144)
Executive appointments (978)
FDA (19731)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1482)
Gene editing (198)
Generative AI (44)
Gene therapy (604)
GLP-1 (970)
Government (4719)
Grass and pollen (8)
Guidances (384)
Healthcare (19057)
HIV (58)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (251)
Immuno-oncology (57)
Indications (110)
Infectious disease (3052)
Inflammatory bowel disease (194)
Inflation Reduction Act (14)
Influenza (117)
Intellectual property (250)
Interviews (319)
IPO (16733)
IRA (50)
Job creations (3717)
Job search strategy (1445)
JPM (58)
Kidney cancer (16)
Labor market (86)
Layoffs (551)
Leadership (31)
Legal (8025)
Liver cancer (91)
Longevity (14)
Lung cancer (650)
Lymphoma (377)
Machine learning (42)
Management (60)
Manufacturing (801)
MASH (165)
Medical device (13963)
Medtech (14016)
Mergers & acquisitions (20228)
Metabolic disorders (1271)
Multiple sclerosis (161)
NASH (16)
Neurodegenerative disease (316)
Neuropsychiatric disorders (88)
Neuroscience (2903)
Neurotech (1)
NextGen: Class of 2026 (6620)
Non-profit (4556)
Now hiring (67)
Obesity (596)
Opinion (260)
Ovarian cancer (166)
Pain (200)
Pancreatic cancer (227)
Parkinson's disease (281)
Partnered (33)
Patents (498)
Patient recruitment (491)
Peanut (58)
People (59372)
Pharmaceutical (63)
Pharmacy benefit managers (29)
Phase 1 (21843)
Phase 2 (30842)
Phase 3 (22999)
Pipeline (5316)
Policy (284)
Postmarket research (2591)
Preclinical (9272)
Press Release (65)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (283)
Rare diseases (844)
Real estate (6072)
Recruiting (70)
Regulatory (24765)
Reports (53)
Research institute (2422)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (86)
Schizophrenia (149)
Series A (240)
Series B (192)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (160)
Sponsored (43)
Startups (3655)
State (2)
Stomach cancer (17)
Supply chain (106)
Tariffs (84)
The Weekly (54)
Vaccines (1045)
Venture capital (88)
Weight loss (383)
Women's health (91)
Worklife (18)
Date
Today (42)
Last 7 days (514)
Last 30 days (2068)
Last 365 days (29948)
2026 (3510)
2025 (30357)
2024 (35408)
2023 (40299)
2022 (51420)
2021 (56032)
2020 (54576)
2019 (46983)
2018 (35407)
2017 (32530)
2016 (31889)
2015 (38026)
2014 (31798)
2013 (26762)
2012 (29008)
2011 (29665)
2010 (27700)
Location
Africa (755)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39833)
Australia (6498)
California (11311)
Canada (3302)
China (1104)
Colorado (478)
Connecticut (476)
Delaware (337)
Europe (87996)
Florida (1691)
Georgia (357)
Hawaii (3)
Idaho (62)
Illinois (863)
India (65)
Indiana (523)
Iowa (22)
Japan (431)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1390)
Massachusetts (8113)
Michigan (325)
Minnesota (634)
Mississippi (5)
Missouri (129)
Montana (33)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3006)
New Mexico (28)
New York (3001)
North Carolina (1477)
North Dakota (8)
Northern California (5523)
Ohio (334)
Oklahoma (21)
Oregon (41)
Pennsylvania (2289)
Puerto Rico (24)
Rhode Island (48)
South America (1129)
South Carolina (67)
South Dakota (1)
Southern California (4403)
Tennessee (174)
Texas (1745)
United States (40163)
Utah (338)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (919)
West Virginia (4)
Wisconsin (110)
Wyoming (2)
729,218 Results for "pari respiratory equipment inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Appointment of Francis Van Parys as Chief Executive Officer
December 8, 2025
·
3 min read
Press Releases
NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
December 15, 2025
·
4 min read
Press Releases
Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System
December 3, 2025
·
6 min read
Press Releases
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
November 14, 2025
·
5 min read
Press Releases
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
November 24, 2025
·
3 min read
Press Releases
ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
January 29, 2026
·
4 min read
Press Releases
Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
September 15, 2025
·
5 min read
Press Releases
Visby Medical Collaborates with Watchmaker Genomics to Enhance Respiratory Pathogen Detection in the At-Home Setting
February 5, 2026
·
3 min read
Press Releases
Abivax announces trading resumption of its ordinary shares on Euronext Paris
July 25, 2025
·
1 min read
Approvals
Precigen Wins First FDA Immunotherapy Nod for Recurrent Respiratory Papillomatosis
Papzimeos is the first immunotherapy approved for recurrent respiratory papillomatosis, a rare lung disorder involving the development of benign tumors in the airways.
August 15, 2025
·
1 min read
·
Tristan Manalac
1 of 72,922
Next
